Literature DB >> 23523494

Implant longevity, complications and functional outcome following proximal femoral arthroplasty for musculoskeletal tumors: a systematic review.

Sivaharan Thambapillary1, Rozalia Dimitriou, Kostantinos G Makridis, Evangelos M Fragkakis, Peter Bobak, Peter V Giannoudis.   

Abstract

A systematic review of the literature was undertaken to evaluate the outcomes and complications following proximal femoral arthroplasty for primary or metastatic tumors affecting the proximal femur. Six hundred sixty-eight patients were available for review. The length of resection ranged from 92 to 212 mm. Limb salvage rate reached over 90%. At 5 years the implant survival rate was 84% and at 10 years, it was 70%. The overall revision rate was 11.1%. Prevalence of venous thrombo-embolic (VTE) events was 8.5%, dislocation rate was 5.8%, infection was 5.2%, local tumor reoccurrence was 4.7%, perioperative mortality was 1.5%, and periprosthetic fracture was 0.6%. Where it was provided the Musculoskeletal Tumour Score was 70.8%. The implants tend to outlive patients with metastatic disease and high-grade localized disease, providing them with a relatively pain-free limb with good mobility and quality of life.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  complications; functional outcome; proximal femoral arthroplasty; quality of life; systematic review; tumor

Mesh:

Year:  2013        PMID: 23523494     DOI: 10.1016/j.arth.2012.10.024

Source DB:  PubMed          Journal:  J Arthroplasty        ISSN: 0883-5403            Impact factor:   4.757


  9 in total

Review 1.  [Complication profile and revision concepts for megaprosthetic reconstruction following tumour resection at the hip].

Authors:  H Fritzsche; J Goronzy; K-D Schaser; C Hofbauer; A E Postler; K P Günther
Journal:  Orthopade       Date:  2020-02       Impact factor: 1.087

2.  [Management of complications following resection and defect reconstruction of tumors near the hip joint].

Authors:  K-D Schaser; I Melcher; S Märdian; C Perka; R Locher; P Schwabe
Journal:  Orthopade       Date:  2014-01       Impact factor: 1.087

Review 3.  [Endoprosthetic tumor replacement : Reconstruction of the extensor mechanism and complications].

Authors:  F Wilken; I J Banke; M Hauschild; S Winkler; K Schott; M Rudert; R V Eisenhart-Rothe
Journal:  Orthopade       Date:  2016-05       Impact factor: 1.087

4.  [Perioperative clinical characteristics of patients with pathological fracture of proximal femur].

Authors:  Y P Cui; C Mi; B Wang; Y X Pa; Y F Lin; X D Shi
Journal:  Beijing Da Xue Xue Bao Yi Xue Ban       Date:  2019-10-18

5.  National use of total hip arthroplasty among patients with a history of breast, lung, prostate, colon or bladder cancer-an analysis of the Medicare population.

Authors:  Samuel Rosas; Karim Sabeh; Jennifer Kurowicki; Leonard Buller; Tsun Yee Law; Martin Roche; Sheila Conway; Victor H Hernandez
Journal:  Ann Transl Med       Date:  2017-12

6.  Rehabilitation of a Patient Receiving a Large-Resection Hip Prosthesis Because of a Phosphaturic Mesenchymal Tumor.

Authors:  Maurizio Lopresti; Primo Andrea Daolio; Jacopo M Rancati; Nicoletta Ligabue; Arnaldo Andreolli; Lorenzo Panella
Journal:  Clin Pract       Date:  2015-11-05

7.  Endoprosthetic Reconstruction for a Displaced Atypical Femoral Fracture in a Cancer Patient with Poor Prognosis.

Authors:  Hironari Tamiya; Hiroki Hagizawa; Takaaki Nakai; Yoshinori Imura; Takaaki Tanaka; Kazuya Oshima; Toshikazu Ito; Norifumi Naka; Shigeyuki Kuratsu
Journal:  Case Rep Orthop       Date:  2018-09-20

8.  Megaprosthesis Reconstruction of the Proximal Femur following Bone Tumour Resection: When Do We Need the Cup?

Authors:  Riccardo Zucchini; Andrea Sambri; Michele Fiore; Claudio Giannini; Davide Maria Donati; Massimiliano De Paolis
Journal:  Hip Pelvis       Date:  2021-09-06

9.  What Sport Activity Levels Are Achieved in Patients After Resection and Endoprosthetic Reconstruction for a Proximal Femur Bone Sarcoma?

Authors:  Gerhard M Hobusch; Jakob Bollmann; Stephan E Puchner; Nikolaus W Lang; Jochen G Hofstaetter; Philipp T Funovics; Reinhard Windhager
Journal:  Clin Orthop Relat Res       Date:  2017-03       Impact factor: 4.176

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.